By Chris Wack
Pulse Biosciences has appointed the company's co-chairman, Paul A. LaViolette, as its new chief executive.
LaViolette replaces Burke T. Barrett, who was named president and CEO of the medical-technology company in May, and stepped down in December.
LaViolette is currently a director for Edwards Lifesciences and chairman of the Innovation Advisory Board at Mass General Brigham.
Write to Chris Wack at chris.wack@wsj.com
(END) Dow Jones Newswires
January 10, 2025 08:43 ET (13:43 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。